Kala Pharmaceuticals

-$0.035 (-5.14%) Today
+$0.0025 (+0.39%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALA and other ETFs, options, and stocks.

About KALA

Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases.

CEO
Mark T. Iwicki
Employees
192
Headquarters
Arlington, Massachusetts
Founded
2009

KALA Key Statistics

Market cap
47.04M
Price-Earnings ratio
—
Dividend yield
—
Average volume
594.71K
High today
$0.68
Low today
$0.615
Open price
$0.68
Volume
609.45K
52 Week high
$6.77
52 Week low
$0.59

KALA News

BenzingaMay 16

Recap: Kala Pharmaceuticals Q1 Earnings

Kala Pharmaceuticals KALA reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Ear

KALA Earnings

-$0.68
-$0.57
-$0.47
-$0.36
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.36 per share
Actual
-$0.40 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure